Dehaier Medical Systems Ltd, which develops, assembles, markets, and sells medical devices and wearable sleep respiratory products in China, today announced that its sleep respiratory solution systems have been adopted by an additional 26 major hospitals and four medical examination centers in Beijing, Tianjin, Shanxi, Hebei, Anhui, Hubei, Shandong, Inner Mongolia, and Gansu provinces. This, combined with the 22 hospitals and six medical examination centers announced last month, brings the total count of hospitals and medical examination centers equipped with the company’s wearable sleep respiratory solution systems to 58 in 14 provinces and cities throughout the country. The company’s wearable sleep respiratory solution features a full range of products and services, including working stations, software, watch-sized sleep diagnostic devices, and PPG sensors. Dehaier’s product line enables obstructive sleep apnea syndrome (OSAS) diagnosis, CPAP treatment, curative effect evaluation, and other related services.
Mr Ping Chen, Dehaier CEO, says in a release: “We are very pleased to see our sleep respiratory business making further inroads into the emerging OSAS treatment and device market in China, which is projected to grow at a compound annual growth rate of 16.5% between 2011 and 2017 and reach $19.7 billion by 2017. As we continue to roll out our nationwide sales and marketing plan, we expect the strong momentum for our wearable sleep respiratory solution systems to continue, allowing us to penetrate between 100 and 150 hospitals and medical examination centers by the end of 2014. Looking ahead, we are increasingly optimistic about the prospects of our sleep respiratory business and view it as an important catalyst, both near- and long-term, for our ongoing transformation into a more sustainable and scalable medical solutions provider.”